Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RVX:CC - Resverlogix: The Future of Drug Development

RVX:CC - Resverlogix: The Future of Drug Development

Resverlogix Corp.

2024-03-27 17:08:02 ET

Developing safe, epigenetic therapeutics for people suffering from chronic illnesses

Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions to key partners.

The Company was founded in 2001 by Donald McCaffrey and Norman Wong. They're a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. They provide novel science, clinical, and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups.

For more information on Resverlogix Corp. (TSX: RVX) please click the investor request info button.

Stock Information
Company Name: Resverlogix Corp.
Stock Symbol: RVX:CC
Market: TSXC
Website: resverlogix.com
Menu
RVX:CC RVX:CC Quote RVX:CC Short RVX:CC News RVX:CC Articles RVX:CC Message Board
Get RVX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...